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Aim: To investigate the effects of L-carnitine (LC) on rats with oxygen-induced retinopathy.
Materials and methods: The study was conducted on 40 Sprague Dawley rat pups. The rat pups were randomly divided into 4 groups:
group 1 (n = 10), the healthy control group with intraperitoneal 0.1 mL/day physiological saline injection; group 2 (n = 10), exposed
to hyperoxygen, did not receive LC but received 0.1 mL/day physiological saline intraperitoneally; group 3 (n = 10), exposed to
hyperoxygen and received 100 mg/kg/day LC intraperitoneally; group 4 (n = 10), exposed to hyperoxygen and received 200 mg/kg/
day LC intraperitoneally. After postnatal day 20, the rat pups were killed and an histological examination was performed on the eyes, in
addition to the detection of plasma malondialdehyde (MDA) levels.
Results: The retinal and choroidal histopathological changes due to hyperoxygen were less in group 3 and minimal in group 4 compared
with group 2. Compared with the healthy control group, the increase in the MDA levels in group 2 was significant (P < 0.05). Compared
with group 2 there was a significant (P < 0.05) decrease in the MDA levels in groups 3 and 4.
Conclusion: LC has beneficial effects on oxygen-induced retinopathy in rats in terms of histopathological changes and MDA levels.
Key words: L-carnitine, malondialdehyde, oxygen toxicity, retinopathy of prematurity

1. Introduction
Retinopathy of prematurity (ROP) in preterm infants is
a leading cause of blindness in childhood. Factors such
as premature birth, low birth weight, blood transfusion,
sepsis, intraventricular hemorrhage, light exposure,
mechanical ventilation, and oxygen therapy increase the
risk of ROP development (1,2).
ROP is a typical and original sign of oxygen toxicity
in advanced premature infants. Supplementary oxygen
therapy contributes to ROP development with toxic
effects in the retina (3–5). Although there is not yet a clear
explanation for their mechanisms, reactive oxygen species
(ROS), generated by higher oxygen concentrations in
tissues, result in oxidative damage to cellular components.
Higher levels of ROS generated by over production or
* Correspondence: opdr_sadullah@yahoo.com

insufficient elimination of ROS results in damage to
cellular proteins, nucleic acids, and membrane lipids
(6,7). ROS-induced oxidation in membrane lipids results
in the production of lipid peroxidation products. Lipid
peroxidation is a well-defined cause of cellular damage
in human beings, and the existence of lipid peroxidation
products is a sign of oxidative damage to cells and tissues.
Lipid peroxides are unstable and decompose to form a
complex series of compounds. These include reactive
carbonyl compounds, among which malondialdehyde
(MDA) is the most abundant (8,9).
The antiperoxidative effect of L-carnitine (LC) on
different tissues has been proposed (10,11). LC protects
tissues with some mechanisms against peroxidative
stress; LC prevents ROS formation generated by the
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xanthine/xanthine oxidase system and reduces possible
damage in the cell membrane (12,13). In addition, LC has
been reported to have a scavenging effect on ROS and a
stabilizing impact on damaged cell membranes (13).
We aimed to determine the choroidal and retinal
histopathological changes and the levels of MDA in rats
with oxygen-induced retinopathy (OIR) that were treated
with LC.

Cambridge, UK) (15). Its level was expressed as nmol/mg
protein.
Statistical analyses were done using SPSS 11.5 for
Windows (SPSS Inc., Chicago, IL, USA). The statistical
significance was calculated using chi-square and oneway ANOVA tests. The results are presented as mean ±
standard deviation and the significance level was set at P
< 0.05.

2. Materials and methods
In this experiment 40 Sprague Dawley rat pups were used.
The rat pups were randomly divided into 4 groups: group
1, (n = 10), the healthy control; group 2 (n = 10), exposed
to hyperoxygen and did not receive LC but did receive
0.1 mL physiological saline intraperitoneally; group 3
(n = 10), exposed to hyperoxygen and received 100 mg/
kg LC intraperitoneally; group 4 (n = 10), exposed to
hyperoxygen and received 200 mg/kg LC intraperitoneally.
A relative hypoxic condition state in the OIR rat model
has been previously described (14). Together with their
mothers, newborn rat pups were exposed to hyperoxygen
(80 ± 1.3% O2) in Plexiglas chambers (Natus Oxydome
II, Seattle, WA, USA) from postnatal (P) day 2 to P14 at
2 h/day in room air. They were then returned to normal
ambient air conditions (room air, 21 ± 1.5% O2) from P14
to P20. Control rat pups were kept in normal room air. All
rat pups were killed on P20.
LC was injected (Carnitine ampule, Sigma-Tau, Rome,
Italy) intraperitoneally in both groups 3 and 4 every day,
starting 1 day before (P1) hyperoxia exposure and ending
14 days after (P14) (total of 15 days). Both the control
group and group 2 were administered daily 0.1 mL of
physiological saline intraperitoneally starting from P1 and
ending at P14 (total of 15 days ).
The animals were housed in facilities accredited by
international guidelines and the studies were approved
by and conducted in accordance with the Institutional
Animal Care and Use Committee of Atatürk University.

3. Results
All ROP models (groups 2, 3, 4) had a characteristic
appearance of severe ROP with peripheral avascular
retina similar to zone II ROP at P14. Inner retinal plexus
vascularization had extended to the ora serrata in the
control group.
Histopathological results in group 1 (healthy control
group): Parts of the tunica vasculosa such as the choroid
and the ciliary body were found to be normal. In both low
and high magnifications of the sections, the neural tunic
was clearly detected.
Histopathological results in group 2: Hyperchromasia
in ciliary epithelial cells, edema under the ciliary
epithelium, and inflammatory cell infiltration under the
ciliary epithelium were detected in all rats. Intense cell
degeneration in the inner nuclear layer and ganglion cells
layer were observed. There was intense degeneration in
nerve fiber and edema among fibers in the inner plexiform
layer. Many necrotic cells and large amounts of cell debris
were detected.
Histopathological results in group 3: Hyperchromasia
in ciliary epithelial cells, a few inflammatory cell
infiltration, and edema under the ciliary epithelium were
determined in the choroid of group 3. Cell degeneration in
the inner nuclear layer and the ganglion cells layer was less
than in group 2. Degeneration in nerve fiber and edema
among fibers in the inner plexiform layer was less than
in group 2. Sparse necrotic cells and cell debris were also
determined.
Histopathological results in group 4: There was no
hyperchromasia in the ciliary epithelial cells. Edema and
inflammatory cell infiltration were not detected under the
ciliary epithelium. There was no degeneration in the inner
nuclear layer and ganglion cells. Degeneration in nerve
fiber and edema among fibers in the inner plexiform layer
was not detected. There were no necrotic cells.
All rats had choroidal changes (hyperchromasia in
ciliary epithelial cells, edema under ciliary epithelium, and
inflammatory cell infiltration under ciliary epithelium) in
groups 2 and 3. All rats had retinal changes (intense cell
degeneration in inner nuclear layer and ganglion cells
layer, degeneration in nerve fibers and edema among

2.1. Tissue preparation
At the end of the experiment, all the animals were killed
by intraperitoneal injections of pentobarbital (200 mg/
kg). The eyes of the rat pups were removed. Each eye was
fixed in a 10% formalin solution for 48–55 h, dehydrated
in a graded alcohol series, embedded in paraffin wax, and
sectioned using a microtome (Leica RM2125RT). Sections
of 5 µm were mounted onto glass slides and stained with
hematoxylin-eosin for routine histological examination.
All sections were studied and photographed by using a
light photomicroscope (Olympus BH40).
Analysis of plasma for MDA levels was determined
in supernatants spectrophotometrically (CE 3041, Cecil,
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fibers in inner plexiform layer, many necrotic cells, and
large amount of cell debris) in groups 2 and 3. No rats had
choroidal or retinal changes in groups 1 and 4. Retinal
and choroidal change levels were found to be increased in
groups 2 and 3 compared with the control and group 4
rats.
The levels of MDA in the samples are all presented in the
Table. Compared with the healthy control group, increases
in the MDA level as an end product of lipid peroxidation
in group 2 were significant (P < 0.05). Compared with
group 2, LC administration in groups 3 and 4 resulted in a
significant decrease in MDA levels (P < 0.05).
4. Discussion
The retina is one of the organs exposed to high oxygen
tension. Retinal over-oxygenation can play an important
role in ROP pathogenesis with rising ROS levels
(16,17). ROS results in more oxidative damage through
lipid peroxidation by invading the double bonds of
polyunsaturated fatty acids. Cell membrane oxidation due
to ROS results in products of lipid peroxidation such as
MDA (18,19). The present study found high levels of MDA
in rats with ROP compared to those without ROP, as in
previous research (19,20).
Some agents were reported in the literature for
protecting the retina in animal models of OIR. In a previous
study, Kaya et al. (21) demonstrated that octreotide acetate
inhibited endothelial cell proliferation in an OIR model
of mouse. They also showed that intravitreal octreotide
acetate decreased apoptotic cell death.
LC is a carrier of long-chain fatty acids and plays an
important role in branched-chain amino acid metabolism,
ketone body utilization, peroxisomal oxidation, and
erythrocyte membrane phospholipid turnover (22).
Carnitine can also act as a chelator by decreasing the
concentration of cytosolic iron, which plays a very
important role in free radical chemistry (23).
The present study, in parallel with other studies,
suggests that LC plays a role against oxidative damage,

preventing lipid peroxidation and supporting the
antioxidant system (24). Other research has shown that
LC reduces acetaminophen-induced high aspartate
transaminase, alanine transaminase, total sialic acid, and
MDA concentrations (25).
Shamsi et al. (26) examined the effect of LC on
oxidative changes in the retinal pigment epithelium (RPE).
They identified a protective effect of LC against oxidative
stress on the RPE. They pointed out that micronutrients
could play a crucial role in oxidation-induced eye diseases
based on the protective effect of LC against H2O2-induced
oxidative damage.
Alagoz et al. (27) examined the efficiency of LC on
ischemia-reperfusion injury in guinea pigs. They found
that the mean MDA value and the tissue thickness of the
LC-treated group were statistically insignificant versus
those of the control group. However, these values were
significantly different in the group receiving saline versus
the control group and that receiving LC. At the end of
study, they concluded that LC might be an alternative drug
for ischemia-reperfusion injury of the retina.
Ates et al. (28) determined the antioxidant properties
of LC in patients with age-related macular degeneration
(AMD). Their study involved 60 patients diagnosed with
early AMD. The patients received LC supplementation for
3 months. At the end of the 3-month period, the MDA
level was significantly reduced in patients treated with LC.
Likewise, Kocer et al. (29) studied the efficiency of
LC on retinal ischemia-reperfusion injury in guinea pigs.
In their study, TBARS levels in retinal tissue were found
lower in the LC group than in the control group and mean
retinal thickness was found to be increased in the control
group when compared to the LC group. They concluded
that LC is effective in preventing retinal injury followed by
ischemia-reperfusion.
Park et al. (30) investigated the effect of triamcinolone
acetonide (TA) on retinal expression of decorin in a rat
model of OIR. The results of their study showed that
neuronal cell death was increased in OIR rats relative to

Table. Levels of MDA in all groups.

Groups

Levels of MDA in plasma
(nmol/mg)

Healthy control
group

Hyperoxia-exposed
group

Group exposed to
hyperoxia and treated
with 100 mg/kg LC

Group exposed to
hyperoxia and treated
with 200 mg/kg LC

Group 1

Group 2

Group 3

Group 4

13.13 ± 1.02

24.44 ± 1.75

13.86 ± 1.00

12.28 ± 1.24

LC: L-carnitine.
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controls. However, treatment with TA restored neuronal
cell death in OIR rats. They suggested that decorin is
involved in hypoxic retinal damage and that TA protects
retinal neurons damaged by relative hypoxia.

In conclusion, LC plays an important role in OIR
in rats, reducing lipid peroxidation and minimizing
histopathological changes. Therefore, it might be used as
an alternative drug with other treatments in OIR.
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